Diagnostic and prognostic role of myoglobin in patients with suspected acute coronary syndrome

American Journal of Cardiology

Volumn 86, Issue 12, 2000, Pages 1371-1374

  Störk, Thomas V ^a   Wu, Alan H B ^b   Müller Bardorff, Margit ^c   Gareis, Ragnar ^a   Müller, Reinhold ^d   Hombach, Vinzenz ^e   Katus, Hugo ^c   Möckel, Martin ^f  

^a Karl Olga Krankenhaus   (Germany)

^b HARTFORD HOSPITAL   (United States)

^c UNIVERSITY OF LÜBECK   (Germany)

^d JAMES COOK UNIVERSITY   (Australia)

^e UNIVERSITY OF ULM   (Germany)

^f HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEART ENZYME; HEPARIN; MYOGLOBIN; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FEMALE; GERMANY; HEART DEATH; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CONFIDENCE INTERVALS; CORONARY DISEASE; CREATINE KINASE; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; FORECASTING; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOGLOBIN; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TROPONIN T;

EID: 0034672659     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01246-7     Document Type: Article

References (20)

1. Biochemical markers of myocardial damage
2. Nomenclature and criteria for diagnosis of ischemic heart disease
3. Development of monoclonal antibodies for an assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarctions
4. Diagnostic efficiency of troponin T measurements in acute myocardial infarction
5. Unstable angina. A classification
6. Emergency room triage of patients with acute chest pains by means of rapid testing for cardiac troponin T or troponin I
7. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease
8. Troponin T in patients with low grade or atypical angina. Identification of a high risk group for short-term and long-term cardiovascular events
9. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes
10. Myoglobin for diagnosis of infarction and reperfusion under clinical conditions
11. Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): Recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes
12. Standards of laboratory practice. Recommendations for use of cardiac markers in coronary artery disease
13. Troponin T and myoglobin in acute coronary syndromes for diagnosis, risk stratification and ruling out of myocardial infarction
14. Diagnostic strategies using myoglobin measurement in myocardial infarction
15. Impact of CK-MB testing policies on hospital length stay and laboratory costs for patients with myocardial infarction or chest pain
16. Early detection of acute myocardial infarction: Additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation
17. Myoglobin/carbonic anhydrase III ratio: Highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction
18. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein
19. Missed diagnosis of acute cardiac ischemia in the emergency department
20. Prognostic value of cardiac troponin T and I elevations in renal disease patients without acute coronary syndromes: A 9-month outcome analysis